Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eidos Therapeutics, Inc. (EIDX) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eidos Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1731831.
Total stock buying since 2018: $349,613,986.
Total stock sales since 2018: $27,291,054.
Total stock option exercises since 2018: $1,225,164.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 14,428,836 | $0 | 13,247 | $1,646,419 | 3,247 | $23,508 |
| 2020 | 0 | $0 | 186,970 | $12,157,142 | 78,116 | $998,529 |
| 2019 | 7,944,804 | $220,024,060 | 258,913 | $11,831,125 | 147,533 | $203,127 |
| 2018 | 7,971,496 | $129,589,926 | 120,797 | $1,656,368 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-01 | 14,428,836 | $0 | 13,247 | $1,646,419 | 3,247 | $23,508 |
| 2020-12 | 0 | $0 | 31,294 | $3,393,145 | 26,294 | $397,039 |
| 2020-11 | 0 | $0 | 27,533 | $2,012,315 | 9,123 | $125,000 |
| 2020-10 | 0 | $0 | 20,474 | $1,412,078 | 10,199 | $73,840 |
| 2020-09 | 0 | $0 | 12,669 | $627,777 | 2,500 | $42,500 |
| 2020-08 | 0 | $0 | 10,000 | $400,630 | 5,000 | $66,000 |
| 2020-07 | 0 | $0 | 5,000 | $250,000 | 0 | $0 |
| 2020-06 | 0 | $0 | 5,000 | $250,000 | 0 | $0 |
| 2020-05 | 0 | $0 | 17,500 | $786,420 | 7,500 | $108,500 |
| 2020-04 | 0 | $0 | 7,000 | $349,580 | 2,000 | $14,480 |
| 2020-03 | 0 | $0 | 18,000 | $915,040 | 8,000 | $57,920 |
| 2020-02 | 0 | $0 | 22,500 | $1,210,087 | 7,500 | $113,250 |
| 2020-01 | 0 | $0 | 10,000 | $550,070 | 0 | $0 |
| 2019-12 | 0 | $0 | 62,500 | $3,728,110 | 40,000 | $149,700 |
| 2019-11 | 0 | $0 | 80,000 | $4,345,410 | 35,000 | $20,650 |
| 2019-10 | 0 | $0 | 5,000 | $182,185 | 0 | $0 |
| 2019-09 | 0 | $0 | 12,500 | $534,627 | 0 | $0 |
| 2019-08 | 0 | $0 | 5,000 | $193,415 | 0 | $0 |
| 2019-07 | 3,529,412 | $105,532,948 | 25,000 | $982,195 | 5,000 | $2,950 |
| 2019-06 | 0 | $0 | 27,000 | $830,669 | 17,000 | $10,030 |
| 2019-05 | 4,415,392 | $114,491,112 | 20,000 | $554,205 | 0 | $0 |
| 2019-04 | 0 | $0 | 10,000 | $246,100 | 5,000 | $2,950 |
| 2019-03 | 0 | $0 | 11,913 | $234,209 | 45,533 | $16,847 |
| 2018-12 | 2,853,848 | $42,589,910 | 120,797 | $1,656,368 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-26 | Bridgebio Pharma, Inc. (10% Owner) | Buy | 14,428,836 | .00 | 0 |
| 2021-01-13 | Sinha Uma (Chief Scientific Officer) | Sale | 10,000 | 123.89 | 1,238,860 |
| 2021-01-12 | Valle Franco (Senior Vice President, Finance) | Sale | 1,747 | 125.44 | 219,152 |
| 2021-01-12 | Valle Franco (Senior Vice President, Finance) | Option Ex | 1,747 | 7.24 | 12,648 |
| 2021-01-11 | Valle Franco (Senior Vice President, Finance) | Sale | 1,500 | 125.61 | 188,407 |
| 2021-01-11 | Valle Franco (Senior Vice President, Finance) | Option Ex | 1,500 | 7.24 | 10,860 |
| 2020-12-15 | Turtle Cameron (Chief Business Officer) | Sale | 26,294 | 111.69 | 2,936,750 |
| 2020-12-15 | Turtle Cameron (Chief Business Officer) | Option Ex | 26,294 | 15.10 | 397,039 |
| 2020-12-02 | Sinha Uma (Chief Scientific Officer) | Sale | 5,000 | 91.28 | 456,395 |
| 2020-11-11 | Turtle Cameron (Chief Business Officer) | Sale | 13,410 | 74.51 | 999,219 |
| 2020-11-09 | Valle Franco (Senior Vice President, Finance) | Sale | 1,623 | 74.93 | 121,609 |
| 2020-11-09 | Valle Franco (Senior Vice President, Finance) | Option Ex | 1,623 | 7.24 | 11,750 |
| 2020-11-02 | Turtle Cameron (Chief Business Officer) | Sale | 12,500 | 71.32 | 891,487 |
| 2020-11-02 | Turtle Cameron (Chief Business Officer) | Option Ex | 7,500 | 15.10 | 113,250 |
| 2020-10-29 | Sinha Uma (Chief Scientific Officer) | Sale | 5,000 | 72.25 | 361,260 |
| 2020-10-08 | Valle Franco (Senior Vice President, Finance) | Sale | 5,199 | 74.85 | 389,150 |
| 2020-10-08 | Valle Franco (Senior Vice President, Finance) | Option Ex | 5,199 | 7.24 | 37,640 |
| 2020-10-07 | Valle Franco (Senior Vice President, Finance) | Sale | 5,444 | 75.08 | 408,746 |
| 2020-10-07 | Valle Franco (Senior Vice President, Finance) | Option Ex | 5,000 | 7.24 | 36,200 |
| 2020-10-01 | Sinha Uma (Chief Scientific Officer) | Sale | 4,831 | 52.35 | 252,922 |
| 2020-09-30 | Sinha Uma (Chief Scientific Officer) | Sale | 169 | 52.04 | 8,794 |
| 2020-09-17 | Fox Jonathan C (See Remarks) | Sale | 5,767 | 50.16 | 289,261 |
| 2020-09-16 | Fox Jonathan C (See Remarks) | Sale | 3,122 | 50.16 | 156,608 |
| 2020-09-15 | Fox Jonathan C (See Remarks) | Sale | 1,000 | 50.06 | 50,064 |
| 2020-09-14 | Fox Jonathan C (See Remarks) | Sale | 111 | 50.00 | 5,550 |
| 2020-09-10 | Turtle Cameron (Chief Business Officer) | Sale | 2,500 | 47.00 | 117,500 |
| 2020-09-10 | Turtle Cameron (Chief Business Officer) | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-08-03 | Turtle Cameron (Chief Business Officer) | Sale | 10,000 | 40.06 | 400,630 |
| 2020-08-03 | Turtle Cameron (Chief Business Officer) | Option Ex | 5,000 | 13.20 | 66,000 |
| 2020-07-07 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 50.00 | 250,000 |
| 2020-06-03 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 50.00 | 250,000 |
| 2020-05-28 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 50.00 | 250,000 |
| 2020-05-26 | Turtle Cameron (Chief Business Officer) | Sale | 2,500 | 47.00 | 117,500 |
| 2020-05-26 | Turtle Cameron (Chief Business Officer) | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-05-01 | Turtle Cameron (Chief Business Officer) | Sale | 10,000 | 41.89 | 418,920 |
| 2020-05-01 | Turtle Cameron (Chief Business Officer) | Option Ex | 5,000 | 13.20 | 66,000 |
| 2020-04-24 | Fox Jonathan C (See Remarks) | Sale | 2,153 | 50.00 | 107,650 |
| 2020-04-23 | Fox Jonathan C (See Remarks) | Sale | 2,847 | 50.00 | 142,350 |
| 2020-04-20 | Valle Franco (Senior Vice President, Finance) | Sale | 2,000 | 49.79 | 99,580 |
| 2020-04-20 | Valle Franco (Senior Vice President, Finance) | Option Ex | 2,000 | 7.24 | 14,480 |
| 2020-03-26 | Valle Franco (Senior Vice President, Finance) | Sale | 5,000 | 48.36 | 241,800 |
| 2020-03-26 | Valle Franco (Senior Vice President, Finance) | Option Ex | 5,000 | 7.24 | 36,200 |
| 2020-03-02 | Valle Franco (Senior Vice President, Finance) | Sale | 3,000 | 52.51 | 157,530 |
| 2020-03-02 | Valle Franco (Senior Vice President, Finance) | Option Ex | 3,000 | 7.24 | 21,720 |
| 2020-03-02 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 51.57 | 515,710 |
| 2020-02-13 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 54.00 | 540,000 |
| 2020-02-03 | Turtle Cameron (Chief Business Officer) | Sale | 12,500 | 53.61 | 670,087 |
| 2020-02-03 | Turtle Cameron (Chief Business Officer) | Option Ex | 7,500 | 15.10 | 113,250 |
| 2020-01-15 | Fox Jonathan C (See Remarks) | Sale | 3,580 | 55.00 | 196,900 |
| 2020-01-14 | Fox Jonathan C (See Remarks) | Sale | 6,420 | 55.01 | 353,170 |
| 2019-12-18 | Sinha Uma (Chief Scientific Officer) | Sale | 12,500 | 62.47 | 780,900 |
| 2019-12-09 | Siu Christine (CFO and Secretary) | Sale | 10,000 | 59.83 | 598,320 |
| 2019-12-09 | Siu Christine (CFO and Secretary) | Option Ex | 10,000 | .59 | 5,900 |
| 2019-12-06 | Turtle Cameron (Chief Business Officer) | Sale | 10,000 | 58.18 | 581,820 |
| 2019-12-06 | Turtle Cameron (Chief Business Officer) | Option Ex | 10,000 | 13.20 | 132,000 |
| 2019-12-04 | Siu Christine (CFO and Secretary) | Sale | 10,000 | 59.00 | 589,960 |
| 2019-12-04 | Siu Christine (CFO and Secretary) | Option Ex | 10,000 | .59 | 5,900 |
| 2019-12-04 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 58.91 | 589,050 |
| 2019-12-03 | Siu Christine (CFO and Secretary) | Sale | 10,000 | 58.81 | 588,060 |
| 2019-12-03 | Siu Christine (CFO and Secretary) | Option Ex | 10,000 | .59 | 5,900 |
| 2019-11-25 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 56.52 | 565,220 |
| 2019-11-22 | Siu Christine (CFO and Secretary) | Sale | 10,000 | 55.00 | 550,030 |
| 2019-11-22 | Siu Christine (CFO and Secretary) | Option Ex | 10,000 | .59 | 5,900 |
| 2019-11-21 | Siu Christine (CFO and Secretary) | Sale | 25,000 | 55.56 | 1,388,950 |
| 2019-11-21 | Siu Christine (CFO and Secretary) | Option Ex | 25,000 | .59 | 14,750 |
| 2019-11-21 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 55.11 | 551,070 |
| 2019-11-20 | Turtle Cameron (Chief Business Officer) | Sale | 10,000 | 55.95 | 559,510 |
| 2019-11-18 | Fox Jonathan C (See Remarks) | Sale | 10,000 | 50.26 | 502,570 |
| 2019-11-15 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 45.61 | 228,060 |
| 2019-10-15 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 36.44 | 182,185 |
| 2019-09-25 | Sinha Uma (Chief Scientific Officer) | Sale | 2,500 | 38.76 | 96,907 |
| 2019-09-16 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 45.74 | 228,720 |
| 2019-09-04 | Turtle Cameron (Chief Business Officer) | Sale | 5,000 | 41.80 | 209,000 |
| 2019-08-15 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 38.68 | 193,415 |
| 2019-07-25 | Sinha Uma (Chief Scientific Officer) | Sale | 5,000 | 36.96 | 184,790 |
| 2019-07-15 | Fox Jonathan C (See Remarks) | Sale | 15,000 | 40.04 | 600,555 |
| 2019-07-10 | Siu Christine (CFO and Secretary) | Sale | 5,000 | 39.37 | 196,850 |
| 2019-07-10 | Siu Christine (CFO and Secretary) | Option Ex | 5,000 | .59 | 2,950 |
| 2019-07-03 | Bridgebio Pharma, Inc. (10% Owner) | Buy | 882,353 | 29.90 | 26,383,237 |
| 2019-07-03 | Kumar Neil (Chief Executive Officer) | Buy | 882,353 | 29.90 | 26,383,237 |
| 2019-07-03 | Satvat Ali J. (Director) | Buy | 882,353 | 29.90 | 26,383,237 |
| 2019-07-03 | Aguiar Eric (Director) | Buy | 882,353 | 29.90 | 26,383,237 |
| 2019-06-26 | Siu Christine (CFO and Secretary) | Option Ex | 17,000 | .59 | 10,030 |
| 2019-06-05 | Siu Christine (CFO and Secretary) | Sale | 17,000 | 30.16 | 512,669 |
| 2019-06-04 | Turtle Cameron (Chief Business Officer) | Sale | 10,000 | 31.80 | 318,000 |
| 2019-05-30 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 32.64 | 163,180 |
| 2019-05-24 | Bridgebio Pharma, Inc. (10% Owner) | Buy | 1,103,848 | 25.93 | 28,622,778 |
| 2019-05-24 | Kumar Neil (Chief Executive Officer) | Buy | 1,103,848 | 25.93 | 28,622,778 |
| 2019-05-24 | Satvat Ali J. (Director) | Buy | 1,103,848 | 25.93 | 28,622,778 |
| 2019-05-24 | Aguiar Eric (Director) | Buy | 1,103,848 | 25.93 | 28,622,778 |
| 2019-05-23 | Sinha Uma (Chief Scientific Officer) | Sale | 5,000 | 27.52 | 137,600 |
| 2019-05-03 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 25.03 | 125,150 |
| 2019-05-01 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 25.66 | 128,275 |
| 2019-04-24 | Siu Christine (CFO and Secretary) | Sale | 5,000 | 26.11 | 130,550 |
| 2019-04-24 | Siu Christine (CFO and Secretary) | Option Ex | 5,000 | .59 | 2,950 |
| 2019-04-15 | Fox Jonathan C (See Remarks) | Sale | 5,000 | 23.11 | 115,550 |
| 2019-03-19 | Siu Christine (CFO and Secretary) | Sale | 11,913 | 19.66 | 234,209 |
| 2019-03-19 | Siu Christine (CFO and Secretary) | Option Ex | 45,533 | .37 | 16,847 |
| 2018-12-10 | Bridgebio Pharma Llc (10% Owner) | Sale | 40,653 | 13.62 | 553,897 |
| 2018-12-07 | Bridgebio Pharma Llc (10% Owner) | Sale | 41,174 | 14.15 | 582,612 |
| 2018-12-06 | Bridgebio Pharma Llc (10% Owner) | Sale | 38,970 | 13.34 | 519,859 |
| 2018-12-05 | Bridgebio Pharma Llc (10% Owner) | Buy | 1,103,848 | 14.01 | 15,464,910 |
| 2018-12-03 | Bridgebio Pharma Llc (10% Owner) | Buy | 1,750,000 | 15.50 | 27,125,000 |
| 2018-06-22 | Bridgebio Pharma Llc (10% Owner) | Buy | 1,000,000 | 17.00 | 17,000,000 |
| 2018-06-22 | Kumar Neil (Chief Executive Officer) | Buy | 1,000,000 | 17.00 | 17,000,000 |
| 2018-06-22 | Satvat Ali J. (Director) | Buy | 1,000,000 | 17.00 | 17,000,000 |
| 2018-06-22 | Shah Rajeev M. (Director) | Buy | 1,058,824 | 17.00 | 18,000,008 |
| 2018-06-22 | Kolchinsky Peter | Buy | 1,058,824 | 17.00 | 18,000,008 |
Insider trading activities including stock purchases, stock sales, and option exercises of EIDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eidos Therapeutics, Inc. (symbol EIDX, CIK number 1731831) see the Securities and Exchange Commission (SEC) website.